When it comes to LBCL relapse in complete remission, ASCT outperforms CAR T-cell therapy.

Published Date: 15 Dec 2023

Improvements in 2-year PFS and OS, but not for primary refractory illness.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Non-Hodgkin lymphomas that are indolent have been linked to psychological distress.

2.

Pulled Myeloma Drug Improves Survival in Trial

3.

The response of bipolar patients to lithium may be predicted by ancestry.

4.

Researchers use AI to monitor side effects of chemotherapy and support families dealing with pediatric cancer.

5.

Asymptomatic Brain Metastases in EGFR-Mutant NSCLC


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot